Table 2 Clinical features of recurrent versus de novo NASH
From: Clinicopathologic features of de novo non-alcoholic steatohepatitis in the post-transplant setting
Clinical Features | Recurrent NASH (n = 19) | De novo (n = 37) | p values |
|---|---|---|---|
Age (years) | 62.7 years | 60.6 years | p = 0.378 |
Gender (% male) | 68% (13) | 62% (23) | p = 0.7715 |
Hypertension (%) | |||
Pre-transplant onset | 21% (4/19) | 54% (20/37) | p = 0.0238 |
Post-transplant onset | 44% (8/19) | 27% (12/37) | p = 0.3653 |
Diabetes (%) | |||
Pre-transplant onset | 58% (11/19) | 11% (4/37) | p = 0.0003 |
Post-transplant onset | 26% (5/19) | 46% (17/37) | p = 0.248 |
Hyperlipidemia (%) | |||
Pre-transplant onset | 21% (4/19) | 3% (1/37) | P = 0.0406 |
Post-transplant | 37% (7/19) | 38% (14/37) | P > 0.9999 |
BMI (average, kg/m2) | 34.2 | 36.1 | p = 0.58 |
Time to diagnosis after transplant (years) | 2.8 years | 4.8 years | p = 0.02 |